Silver Book Fact

“Sherri Selph was 41 when she was first diagnosed with second-stage congestive heart failure. However, her rapidly diminishing health led to a diagnosis of end-stage heart disease. A heart transplant was not an option. Survival statistics for patients with Sherrie’s condition are grim. Even with the best treatment available, only 50 percent of heart failure patients live beyond a year.
Her doctor suggested that Sherri enroll in a clinical trial. Sherri soon became a patient and a member of the group that received an implantable heart pump.
The results were immediate. Four days after receiving her heart pump Sherri was back on her feet. ‘I could not believe it. The pump had given me back my life,’ she said. ‘Without this procedure, I would not have lived to see my youngest grandson who is now two and a half years old.’ Sherri is now back in South Carolina with her heart pump and her five grand-children, who prefer that she stay right where she is.”

Investment in Research Saves Lives and Money. http://www.researchamerica.org/advocacy/investment.html. Published 2005

Reference

Title
Investment in Research Saves Lives and Money
Publisher
Research!America
Publication Date
Published 2005
Authors
Research!America
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • AFib practice guidelines reduce direct health care costs
    The use of practice guidelines in atrial fibrillation (AF) patients significantly decreased hospitalization and resource utilization—with an average decrease in 30-day total direct health care costs of around $1,400 per patient.  
  • Increased use of a blood-thinning drug saves $600 million annually, because of the strokes it prevents.  
  • Every year, around 250,000 Americans have an automatic intracardiac defibrillator (ICD) implanted. Data from clinical trials that compares ICDs to antiarrhythmic drugs show that the ICDs reduce sudden cardiac death…  
  • Cost-effectiveness of SAVR
    The cost-effectiveness ratio for surgical aortic valve replacement (SAVR), compared to no surgery, was estimated at $13,528 per quality-adjusted life year (QALY) (~$17,225 in 2017 dollars).  
  • Between 1984 and 1998, the cost of treating heart attack patients rose $10,000. However, medical technology increased the life expectancy of heart attack patients by an average of 1 year-a…